Virnich Daniel 4

What Happened
Daniel Virnich, CEO of Oncology Institute, Inc. (TOI), disposed of 11,834 shares on March 17, 2026. The shares were sold at $3.59 each for a total transaction value of approximately $42,484. The sale was executed by the issuer to cover tax withholding obligations arising from the vesting of an RSU award.

Key Details

• Transaction date: 2026-03-17; filing date (Form 4): 2026-03-18 (appears timely).
• Shares sold: 11,834 at $3.59 per share; total value ≈ $42,484.
• Reason/footnote: Issuer executed the sale to cover tax liabilities from RSU vesting (tax withholding/cashless sale).
• Shares owned after transaction: Not provided in the excerpt of the filing.
• Transaction type: Disposition (routine tax withholding), not an open-market sell initiated by the insider.

Context
Tax-withholding sales following RSU vesting are common and are generally administrative (to satisfy tax obligations) rather than a direct signal of the insider’s view on the company. Purchases by insiders are typically more indicative of bullish sentiment; this type of sale is usually routine.